You are here » Home » Companies » Company Overview » Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd.

BSE: 531569 Sector: Health care
NSE: N.A. ISIN Code: INE860D01013
BSE LIVE 15:40 | 22 Aug 7.12 -0.20
(-2.73%)
OPEN

7.60

HIGH

7.60

LOW

7.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 7.60
PREVIOUS CLOSE 7.32
VOLUME 2700
52-Week high 27.90
52-Week low 6.60
P/E
Mkt Cap.(Rs cr) 4
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 7.60
CLOSE 7.32
VOLUME 2700
52-Week high 27.90
52-Week low 6.60
P/E
Mkt Cap.(Rs cr) 4
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Sanjivani Paranteral Ltd. (SANJIVPARANT) - Company History

Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral is jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project. The promoters have received firm enquiries from reputed phamaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampoules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.